Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
08/19/2004 | WO2004069284A2 Ultrasound contrast agents and process for the preparation thereof |
08/19/2004 | WO2004069283A1 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection |
08/19/2004 | WO2004069281A1 Bifunctional molecules comprising at least one integrin-binding and their use in imaging and therapy of angiogenesis and related disorders |
08/19/2004 | WO2004069269A1 Method for making a cell more susceptible for a compound by expressing the protein, on which said compound acts, in said cell |
08/19/2004 | WO2004069193A2 Methods and compositions for inhibiting cholesterol uptake |
08/19/2004 | WO2004069179A2 Improved thickened beverages for dysphagia |
08/19/2004 | WO2004069169A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
08/19/2004 | WO2004069153A2 Apparatus, system and method for generating bubbles on demand |
08/19/2004 | WO2004042353A3 Identifying therapeutic compounds based on their physical-chemical properties |
08/19/2004 | WO2003068919A3 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
08/19/2004 | WO2003006625A8 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
08/19/2004 | US20040162243 Compositions of S-nitrosothiols and methods of use |
08/19/2004 | US20040161815 in amidation of folded polypeptides and proteins based on the use of a chemical structure element comprising an imidazole function; solid phase synthesis |
08/19/2004 | US20040161451 Soft filament occlusive device delivery system |
08/19/2004 | US20040161384 Ultrasound contrast agents; dissolving subliming, water insoluble substance then polymer in nonpolar solvent; emulsifying, adding surfactant and hardening; reproducible size |
08/19/2004 | US20040161383 Diagnostic agents for pancreatic exocrine function |
08/19/2004 | CA2694872A1 Improved thickened beverages for dysphagia |
08/19/2004 | CA2514307A1 Improved radiometal complex compositions |
08/18/2004 | CN1162186C Low-density gastrointestinal contrast medium and its production process |
08/17/2004 | US6776977 Polypodal chelants for metallopharmaceuticals |
08/17/2004 | US6776761 Introducing contrast agent of microbubbles having constant wall thickness to diameter ratio and threshold intensity of ultrasonic power of microbubble rupture within power range useful for diagnostic imaging, applying ultrasonic signal |
08/12/2004 | WO2004068405A2 High contrast optoacoustical imaging using nanoparticles |
08/12/2004 | WO2004067483A2 Chelating agents with lipophilic carriers |
08/12/2004 | WO2004066995A1 Method for treating ischemic stroke with melatonin |
08/12/2004 | WO2003015606A3 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
08/12/2004 | US20040157953 Materials for filling cavities in the body |
08/12/2004 | US20040157951 Monodisperse preparations useful with implanted devices |
08/12/2004 | US20040157905 Administering protoporhyrin ix ; detection accumulation in cells; measurement cell proliferation |
08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
08/12/2004 | US20040156786 Paramagnetic complexes as contrast agents for magnetic resonance imaging; chelate compounds |
08/12/2004 | US20040156785 Magnetic resonance or optical imaging prodrug contrast agent having lower affinity for tissue protein than bioactivated form |
08/12/2004 | US20040156784 Paramagnetic nanoparticle |
08/12/2004 | US20040156783 Complexes of cyanine, indocyanine, phthalocyanine, rhodamine, oxazine, thiazine, phenoselenazines, fluoresceins, porphyrin, squaraine, corrins, croconium, azo, methine and/or indolenium dye linked with receptor binding molecules; tumors |
08/12/2004 | US20040156782 Methods of using indocyanine green (ICG) dye |
08/12/2004 | US20040156781 Polymeric materials for site specific delivery to the body |
08/12/2004 | CA2514201A1 Chelating agents with lipophilic carriers |
08/11/2004 | EP1445622A2 Hyperpolarized gas transport device |
08/11/2004 | EP1444991A1 Novel targeted compositions for diagnostic and therapeutic use |
08/11/2004 | EP1444990A1 Improved Radiometal Complex Compositions |
08/11/2004 | EP1444236A1 Separation of regioisomers of metal phthalocyanines |
08/11/2004 | EP1443972A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
08/11/2004 | EP1443963A2 Antibody targeting compounds |
08/11/2004 | EP1443953A2 Detection and treatment of intravascular lesions |
08/11/2004 | EP1443899A2 Bowel cleansing agent |
08/11/2004 | EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents |
08/11/2004 | EP1443860A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
08/11/2004 | EP1131280B1 Preparation of 5-amino-isophthalamides |
08/11/2004 | EP1028991B1 Strictly alternating poly(alkylene oxide ether) copolymers |
08/11/2004 | EP0787017B1 Diagnostic preparation for detection of helicobacter pylori |
08/11/2004 | CN1519041A Method and equipment for setting medical care device of ultrasound microbubble contrast media to form embolism in capillary vessel |
08/11/2004 | CN1161324C Yellow polymorph of 5-amino-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide |
08/10/2004 | US6774228 1,4,7,10-tetrazacyclododecanes capable of reacting with monoclonal or polyclonal antibody; imaging |
08/10/2004 | US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments) |
08/10/2004 | US6773696 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region |
08/08/2004 | CA2619590A1 Solution based methacholine formulations |
08/05/2004 | WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
08/05/2004 | WO2004065567A2 Brain progenitor cell-based assay, and related methods and compositions |
08/05/2004 | WO2004064869A2 Amyloid-binding, metal-chelating agents |
08/05/2004 | WO2004064768A2 Animal model for alzheimer's disease |
08/05/2004 | WO2004064751A2 Nanoparticle based stabilization of ir fluorescent dyes |
08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
08/05/2004 | WO2004064740A2 Sperm specific lysozyme-like proteins |
08/05/2004 | WO2004064714A2 Animal model for obesity independently of insulin resistance |
08/05/2004 | WO2004064611A2 Resorbable radiopaque markers and related medical implants |
08/05/2004 | WO2004043513A3 Surface dissolution and/or bulk erosion controlled release compositions and devices |
08/05/2004 | WO2004026100A3 Using magnetic resonance imaging to directly map neuronal activity |
08/05/2004 | WO2003084386A3 Methods for ultrasonic imaging and treating diseased tissues |
08/05/2004 | WO2003045979A3 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
08/05/2004 | US20040152157 G-protein coupled receptors |
08/05/2004 | US20040152144 Novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
08/05/2004 | US20040152143 Growth differentiation factor-9 |
08/05/2004 | US20040152068 Ocular diagnosis of Alzheimer's disease |
08/05/2004 | US20040151707 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
08/05/2004 | US20040151702 Production and use of a suspension composition comprising an ultrasound contrast medium |
08/05/2004 | US20040151668 Stool marker |
08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
08/05/2004 | US20040151666 Rodent mammary window for intravital microscopy of orthotopic breast cancer and related method |
08/05/2004 | DE10046465B4 Verwendung von Fluorpropan als Spurengas zur Bestimmung der funktionellen Lungenresidualkapazität Use of fluorine propane as a trace gas for determining the functional Lungenresidualkapazität |
08/05/2004 | CA2516116A1 Nanoparticle based stabilization of ir fluorescent dyes |
08/05/2004 | CA2514200A1 Amyloid-binding, metal-chelating agents |
08/05/2004 | CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
08/04/2004 | EP1442751A1 Method of imaging |
08/04/2004 | EP1442064A2 Kinases and phosphatases |
08/04/2004 | EP1441773A1 Pacap compositions and methods for tumor imaging and therapy |
08/04/2004 | EP1441765A2 Method for preparation of single chain antibodies |
08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
08/04/2004 | EP1113823B1 Chiral radio-contrast agents |
08/04/2004 | CN1518479A Stabilization and terminal sterilization of phospholipid formulations |
08/03/2004 | US6772000 Magnetic resonance imaging devices with a contrast medium for improved imaging |
08/03/2004 | US6770787 Heavier halogen atom substituted squaraine based dyes, process for the preparation thereof and use thereof as sensitizers for photodynamic, therapeutical and industrial applications |
08/03/2004 | US6770261 Magnetic resonance imaging agents for the detection of physiological agents |
08/03/2004 | CA2142599C Method for diagnosing and monitoring sepsis |
08/03/2004 | CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance |
07/29/2004 | WO2004064109A2 Water soluble metal and semiconductor nanoparticle complexes |
07/29/2004 | WO2004063354A2 Compositions and methods for characterizing and regulating wnt pathways |
07/29/2004 | WO2004063200A1 Porphyrin derivatives |
07/29/2004 | WO2004063093A1 Process and system for producing nuclear spin polarized xenon gas |
07/29/2004 | WO2004062627A2 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |